Mechanisms involved in cardioprotective effects of pravastatin administered during reoxygenation in human myocardium in vitro

Anesthesiology

Volumn 116, Issue 4, 2012, Pages 824-833

  Lemoine, Sandrine ^a   Allouche, Stéphane ^b,c   Coulbault, Laurent ^b,c   Cornet, Valérie ^a   Massetti, Massimo ^b   Galera, Philippe ^d   Gérard, Jean Louis ^b   Hanouz, Jean Luc ^b  

^a Laboratory of Experimental Anesthesiology and Cellular Physiology EA3212   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c UPRES EA3919   (France)

^d UNIVERSITÉ DE CAEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACTYLOSIDE; CASPASE 3; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PRAVASTATIN; PROTEIN BAD; PROTEIN BCL 2; PROTEIN KINASE PIM 1;

ADULT; AGED; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOBLOTTING; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REOXYGENATION; WESTERN BLOTTING;

AGED; CARDIOTONIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; ORGAN CULTURE TECHNIQUES; OXYGEN CONSUMPTION; PRAVASTATIN;

EID: 84859110726     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31824be77c     Document Type: Article

References (41)

1. Andreadou I, Iliodromitis EK, Koufaki M, Farmakis D, Tsotinis A, Kremastinos DT: Alternative pharmacological interventions that limit myocardial infarction. Curr Med Chem 2008; 15:3204-13
2. Yellon DM, Hausenloy DJ: Myocardial reperfusion injury. N Engl J Med 2007; 357:1121-35
3. Kersten JR, Fleisher LA: Statins: The next advance in cardioprotection? ANESTHESIOLOGY 2006; 105:1079-80 (Pubitemid 44815506)
4. Le Manach Y, Ibanez Esteves C, Bertrand M, Goarin JP, Fléron MH, Coriat P, Koskas F, Riou B, Landais P: Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing vascular surgery. ANESTHESIOLOGY 2011; 114:98-104
5. Schouten O, Boersma E, Hoeks SE, Benner R, van Urk H, van Sambeek MR, Verhagen HJ, Khan NA, Dunkelgrun M, Bax JJ, Poldermans D, Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group: Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009; 361:980-9
6. Ludman A, Venugopal V, Yellon DM, Hausenloy DJ: Statins and cardioprotection: More than just lipid lowering? Pharmacol Ther 2009; 122:30-43
7. Verma S, Rao V, Weisel RD, Li SH, Fedak PW, Miriuka S, Li RK: Novel cardioprotective effects of pravastatin in human ventricular cardiomyocytes subjected to hypoxia and reoxygenation: Beneficial effects of statins independent of endothelial cells. J Surg Res 2004; 119:66-71 (Pubitemid 38581987)
8. Garlid KD, Costa AD, Quinlan CL, Pierre SV, Dos Santos P: Cardioprotective signaling to mitochondria. J Mol Cell Cardiol 2009; 46:858-66
9. Javadov S, Karmazyn M, Escobales N: Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J Pharmacol Exp Ther 2009; 330: 670-8
10. Zhao ZQ, Velez DA, Wang NP, Hewan-Lowe KO, Nakamura M, Guyton RA, Vinten-Johansen J: Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 2001; 6:279-90 (Pubitemid 32708522)
11. Yu LN, Yu J, Zhang FJ, Yang MJ, Ding TT, Wang JK, He W, Fang T, Chen G, Yan M: Sevoflurane postconditioning reduces myocardial reperfusion injury in rat isolated hearts via activation of PI3K/Akt signaling and modulation of Bcl-2 family proteins. J Zhejiang Univ Sci B 2010; 11:661-72
12. Penna C, Perrelli MG, Raimondo S, Tullio F, Merlino A, Moro F, Geuna S, Mancardi D, Pagliaro P: Postconditioning induces an anti-apoptotic effect and preserves mitochondrial integrity in isolated rat hearts. Biochim Biophys Acta 2009; 1787: 794-801
13. Lemoine S, Zhu L, Beauchef G, Lepage O, Babatasi G, Ivascau C, Massetti M, Galera P, Gérard JL, Hanouz JL: Role of 70-kDa ribosomal protein S6 kinase, nitric oxide synthase, glycogen synthase kinase-3 β, and mitochondrial permeability transition pore in desflurane-induced postconditioning in isolated human right atria. ANESTHESIOLOGY 2010; 112:1355-63
14. Amour J, Kersten JR: Diabetic cardiomyopathy and anesthesia: Bench to bedside. ANESTHESIOLOGY 2008; 108:524-30 (Pubitemid 351304244)
15. Amour J, Brzezinska AK, Jager Z, Sullivan C, Weihrauch D, Du J, Vladic N, Shi Y, Warltier DC, Pratt PF Jr, Kersten JR: Hyperglycemia adversely modulates endothelial nitric oxide synthase during anesthetic preconditioning through tetrahydrobiopterin- and heat shock protein 90-mediated mechanisms. ANESTHESIOLOGY 2010; 112:576-85
16. Byington RP, Jukema JW, Salonen JT, Pitt B, Bruschke AV, Hoen H, Furberg CD, Mancini GB: Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation 1995; 92:2419-25
17. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335:1001-9 (Pubitemid 26338729)
18. Lee TM, Su SF, Chou TF, Tsai CH: Effect of pravastatin on myocardial protection during coronary angioplasty and the role of adenosine. Am J Cardiol 2001; 88:1108-13 (Pubitemid 33043840)
19. Bao N, Minatoguchi S, Kobayashi H, Yasuda S, Kawamura I, Iwasa M, Yamaki T, Sumi S, Misao Y, Arai M, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H: Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits. Circ J 2007; 71:1622-8 (Pubitemid 47529667)
20. Bergmann MW, Rechner C, Freund C, Baurand A, El Jamali A, Dietz R: Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: Role for glycogen synthase kinase 3beta and transcription factor beta-catenin. J Mol Cell Cardiol 2004; 37:681-90 (Pubitemid 39194560)
21. Lakatta EG: Research agenda for cardiovascular aging: Humans to molecules. Am J Geriatr Cardiol 2000; 9:251- 62
22. Mio Y, Bienengraeber MW, Marinovic J, Gutterman DD, Rakic M, Bosnjak ZJ, Stadnicka A: Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes: Roles for mitochondrial respiration and sarcolemmal adenosine triphosphate-sensitive potassium channel activity. ANESTHESIOLOGY 2008; 108:612-20 (Pubitemid 351440581)
23. Sanada S, Asanuma H, Minamino T, Node K, Takashima S, Okuda H, Shinozaki Y, Ogai A, Fujita M, Hirata A, Kim J, Asano Y, Mori H, Tomoike H, Kitamura S, Hori M, Kitakaze M: Optimal windows of statin use for immediate infarct limitation: 5′-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase. Circulation 2004; 110: 2143-9 (Pubitemid 39372492)
24. Thuc LC, Teshima Y, Takahashi N, Nagano-Torigoe Y, Ezaki K, Yufu K, Nakagawa M, Hara M, Saikawa T: Mitochondrial K(ATP) channels-derived reactive oxygen species activate pro-survival pathway in pravastatin-induced cardioprotection. Apoptosis 2010; 15:669-78
25. Argaud L, Gateau-Roesch O, Muntean D, Chalabreysse L, Loufouat J, Robert D, Ovize M: Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 2005; 38:367-74 (Pubitemid 40215206)
26. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231-41 (Pubitemid 27456390)
27. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ: Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14 -3-3 not BCL-X(L). Cell 1996; 87:619-28 (Pubitemid 26386936)
28. Kirshenbaum LA, de Moissac D: The Bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 1997; 96:1580-5 (Pubitemid 27375355)
29. Kang PM, Haunstetter A, Aoki H, Usheva A, Izumo S: Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res 2000; 87:118-25 (Pubitemid 30616907)
30. Zhu L, Yu Y, Chua BH, Ho YS, Kuo TH: Regulation of sodium-calcium exchange and mitochondrial energetics by Bcl-2 in the heart of transgenic mice. J Mol Cell Cardiol 2001; 33:2135-44 (Pubitemid 34073056)
31. Lilly M, Sandholm J, Cooper JJ, Koskinen PJ, Kraft A: The PIM-1 serine kinase prolongs survival and inhibits apoptosisrelated mitochondrial dysfunction in part through a Bcl-2-dependent pathway. Oncogene 1999; 18:4022-31 (Pubitemid 29361341)
32. Muraski JA, Rota M, Misao Y, Fransioli J, Cottage C, Gude N, Esposito G, Delucchi F, Arcarese M, Alvarez R, Siddiqi S, Emmanuel GN, Wu W, Fischer K, Martindale JJ, Glembotski CC, Leri A, Kajstura J, Magnuson N, Berns A, Beretta RM, Houser SR, Schaefer EM, Anversa P, Sussman MA: Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med 2007; 13:1467-75 (Pubitemid 350224243)
33. Borillo GA, Mason M, Quijada P, Völkers M, Cottage C, McGregor M, Din S, Fischer K, Gude N, Avitabile D, Barlow S, Alvarez R, Truffa S, Whittaker R, Glassy MS, Gustafsson AB, Miyamoto S, Glembotski CC, Gottlieb RA, Brown JH, Sussman MA: Pim-1 kinase protects mitochondrial integrity in cardiomyocytes. Circ Res 2010; 106:1265-74
34. Koitabashi Y, Kumai T, Matsumoto N, Watanabe M, Sekine S, Yanagida Y, Kobayashi S: Orange juice increased the bioavailability of pravastatin, 3-hydroxy-3-methylglutaryl CoA reductase inhibitor, in rats and healthy human subjects. Life Sci 2006; 78:2852-9
35. Yu CK, Li YH, Wong GT, Wong TM, Irwin MG: Remifentanil preconditioning confers delayed cardioprotection in the rat. Br J Anaesth 2007; 99:632-8 (Pubitemid 351773220)
36. Zhang Y, Irwin MG, Wong TM, Chen M, Cao CM: Remifentanil preconditioning confers cardioprotection via cardiac κ- and δ-opioid receptors. ANESTHESIOLOGY 2005; 102:371-8 (Pubitemid 40189086)
37. Boengler K, Schulz R, Heusch G: Loss of cardioprotection with ageing. Cardiovasc Res 2009; 83:247-61
38. Saito W, Noguchi K, Okazaki K, Matsuda T, Kato Y, Tanaka H, Shigenobu K: Temperature-sensitive effects of potassium channel openers on isolated guinea pig myocardium and aorta. J Cardiovasc Pharmacol 1998; 31:327-9 (Pubitemid 28099176)
39. Gateau-Roesch O, Argaud L, Ovize M: Mitochondrial permeability transition pore and postconditioning. Cardiovasc Res 2006; 70:264-73
40. Dow J, Bhandari A, Kloner RA: Ischemic postconditioning's benefit on reperfusion ventricular arrhythmias is maintained in the senescent heart. J Cardiovasc Pharmacol Ther 2008; 13:141-8 (Pubitemid 351704170)
41. Sivaraman V, Mudalagiri NR, Di Salvo C, Kolvekar S, Hayward M, Yap J, Keogh B, Hausenloy DJ, Yellon DM: Postconditioning protects human atrial muscle through the activation of the RISK pathway. Basic Res Cardiol 2007; 102:453-9 (Pubitemid 47278818)